AETHLON MEDICAL INC (AEMD) is a publicly traded Healthcare sector company. As of July 6, 2026, AEMD trades at $0.74 with a market cap of $1.68M and a P/E ratio of -0.07. AEMD moved +1.27% today. Year to date, AEMD is -73.60%; over the trailing twelve months it is -94.27%. Its 52-week range spans $0.65 to $84.40. Analyst consensus is neutral with an average price target of $2.00. Rallies surfaces AEMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Aethlon Medical Prices 5.6M Shares and Warrants at $0.7101 in $4M ATM Offering: Aethlon Medical is offering 5,633,009 shares (or pre-funded warrants) and equal number of warrants in an at-the-market offering priced at $0.7101 per unit to raise about $4.0 million in gross proceeds. Net proceeds will fund research and development, ongoing clinical trials, capital expenditures, working capital and potential in-license or acquisitions.
| Metric | Value |
|---|---|
| Price | $0.74 |
| Market Cap | $1.68M |
| P/E Ratio | -0.07 |
| EPS | $-10.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $84.40 |
| 52-Week Low | $0.65 |
| Volume | 329.65K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-7.15M |
| Gross Margin | 0.00% |
1 analysts cover AEMD: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.00.